Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants.
Federico Martinón-Torres, Hanna Czajka, Kimberly J. Center, Jacek Wysocki, Ewa Majda-Stanislawska, Felix Omeñaca, Enrique Bernaola Iturbe, Daniel Blazquez Gamero, Ana Concheiro-Guisán, Francisco Gimenez-Sanchez, Leszek Szenborn, Peter C. Giardina, Scott Patterson, William C. Gruber, Daniel A. Scott, Alejandra Gurtman
Journal:
Pediatrics
Publicación independiente
Impact factor
5.359
Q1
Vaccine evaluation: lessons from a meningococcal B vaccine.
Sarfatti A, Martinón-Torres F, Nadel S
Journal:
Arch Dis Child
Publicación independiente
Impact factor
3.041
Q1
Should the Indication of Pneumococcal Polysaccharide Vaccine in Children Be Definitively Withdrawn?
Federico Martinón Torres
Journal:
Clin Infect Dis
Publicación independiente
Impact factor
8.313
Q1
Rotavirus vaccination in Europe: drivers and barriers.
N Parez, C Giaquinto, C Du Roure, F Martinon-Torres, V Spoulou, P Van Damme, T Vesikari
Journal:
Lancet Infect Dis
Publicación independiente
Impact factor
24.446
Q1
RSV—Still More Questions Than Answers
Louis Bont, Eugenio Baraldi, Brigitte Fauroux, Anne Greenough, Terho Heikkinen, Paolo Manzoni, Federico Martinón-Torres, Harish Nair and Nikolaos G. Papadopoulos, on behalf of ReSViNET
Journal:
Pediatr Infect Dis J.
Publicación independiente
Impact factor
2.126
Q2
Prognostic markers of meningococcal disease in children: recent advances and future challenges.
María Montero-Martín, David P Inwald, Enitan D Carrol & Federico Martinón-Torres
Journal:
Expert Rev Infect Ther
Publicación independiente
Impact factor
3.767
Q1
Pneumococcal Vaccination in Europe: Schedule Adherence
Alain Gervaix; Filippo Ansaldi; Antonio Brito-Avô; Chiara Azzari, Markus Knuf; Federico Martinón-Torres; David Tuerlinckx; Myint TinTin Htar, and George A. Syrogiannopoulos
Journal:
Clin Therap
Publicación independiente
Impact factor
3.119
Q2
Overuse of bronchodilators and steroids in bronchiolitis of different severity Bronchiolitis-study of variability, appropriateness, and adequacy
C. Ochoa Sangrador, J. González de Dios, Research Group of the aBREVIADo Project
Journal:
Allergol Immunopathol (Madr)
Publicación independiente
Impact factor
1.276
Q3
Year:
2014
Doi:
Caracterización microbiológica de las gastroenteritis agudas virales atendidas en un servicio de pediatría en un área de alta cobertura vacunal frente a rotavirus
Carlos García-Magán, María José de Castro-López, José Llovo-Taboada, Carmen Curros-Novo, Miriam Puente-Puig, Alicia Sánchez-Fauquier, Federico Martinón-Torres
Journal:
Enferm Infecc Microbiol Clin
Publicación independiente
Impact factor
1.654
Q3
Evolving Role of 13-valent Pneumococcal Conjugate Vaccine in Clinical Practice
Azzari C, Martinón-Torres F, Schmitt HJ, Dagan R.
Journal:
Pediatr Infect Dis J.
Publicación independiente
Impact factor
2.126
Q2
Evaluating the accuracy of AIM panels at quantifying genome ancestry
Jacobo Pardo-Seco, Federico Martinón-Torres and Antonio Salas
Journal:
BMC Genomics
Publicación independiente
Impact factor
3.594
Q2
Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome
Jan De Waele, Jeffrey Lipman, Yasser Sakr, John C Marshall, Philippe Vanhems, Casiano Barrera Groba, Marc Leone, Jean-Louis Vincent and for the EPIC II Investigators
Journal:
BMC Infec Dis
Publicación independiente
Impact factor
2.688
Q3
Year:
2014
Doi:
Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study
Thierry Gustot, Peter Felleiter, Peter Pickkers, Yasser Sakr, Jordi Rello, Dimitrios Velissaris, Charalampos Pierrakos, Fabio S. Taccone, Pavel Sevcik, Christophe Moreno, Jean-Louis Vincent and for the EPIC II Group of Investigators
Journal:
Liver Internat.
Publicación independiente
Impact factor
5.175
Q1
Year:
2014
Doi:
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants.
Federico Martinon-Torres, Francisco Gimenez-Sanchez, Enrique Bernaola-Iturbe,Javier Diez-Domingo, Qin Jiang, John L. Perez
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Fe de errores de «Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes»
A. Gil, D. Barranco, J. Batalla, J.M. Bayas, M. Campins, P. Gorrotxategi Gorrotxategi, J. Lluch, F. Martinon-Torres, M.J. Mellado, D. Moreno-Pérez, B. Uriel, J.A. Vázquez
Journal:
An Pediatr
Publicación independiente
Impact factor
1.313
Q4
A Genome-Wide Study of Modern-Day Tuscans: Revisiting Herodotus’s Theory on the Origin of the Etruscans
Jacobo Pardo-Seco, Alberto Gómez-Carballa, Jorge Amigo, Federico Martinón-Torres, Antonio Salas
Journal:
PLoS ONE
Publicación independiente
Impact factor
2.740
Q2
Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes
A. Gil, D. Barranco, J. Batalla, J.M. Bayas, M. Campins, P. Gorrotxategi Gorrotxategi, J. Lluch, F. Martinon-Torres, M.J. Mellado, D. Moreno-Pérez, B. Uriel, J.A. Vázquez
Journal:
An Pediatr
Publicación independiente
Impact factor
1.313
Q4
Immunisation against meningococcus B: the case of Spain
Federico Martinón Torres
Journal:
Lancet
Publicación independiente
Impact factor
60.392
Q1
Read my lips: oral manifestations of systemic diseases.
de Castro López MJ, Illade Quinteiro L, Martinón Torres F, Cutrín Prieto JM.
Journal:
Journal of Pediatrics
Publicación independiente
Impact factor
3.700
Q1
Dr. Google: what about the human papillomavirus vaccine?
Leticia Pías-Peleteiro, Javier Cortés-Bordoy, and Federico Martinón-Torres
Journal:
Human Vaccines & Immunother
Publicación independiente
Impact factor
2.619
Q2
Adaptive support ventilation: State of the art review.
Fernández J, Miguelena D, Mulett H, Godoy J, Martinón-Torres F.
Journal:
Indian J Crit Care Med
Publicación independiente
Impact factor
Indian Signatures in the Westernmost Edge of the European Romani Diaspora: New Insight from Mitogenomes
Alberto Gómez-Carballa, Jacobo Pardo-Seco, Laura Fachal, Ana Vega, Miriam Cebey, Nazareth Martinón-Torres, Federico Martinón-Torres, Antonio Salas
Journal:
PLoS ONE
Publicación independiente
Impact factor
2.740
Q2
Transcriptomic profiling in childhood H1N1/09 influenza reveals reduced expression of protein synthesis genes.
Jethro A. Herberg, Myrsini Kaforou, Stuart Gormley, Edward R. Sumner, Sanjay Patel, Kelsey D. J. Jones, Stéphane Paulus, Colin Fink, Federico Martinon-Torres, Giovanni Montana, Victoria J. Wright, and Michael Levin
Journal:
J. Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule
Gail L. Rodgersa, Susanna Esposito, Nicola Principi, Maricruz Gutierrez-Brito, Javier Diez-Domingo, Andrew J. Pollard, Matthew D. Snape,Federico Martinón-Torres, William C. Gruber, Scott Patterson, Allison Thompson,Alejandra Gurtman, Peter Paradiso, Daniel A. Scott
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
No results found.
BIOMARKERS FOR THE DISCRIMINATION OF ACUTE KAWASAKI DISEASE FROM INFECTIONS IN CHILDHOOD
Judith Zandstra, Annemarie van de Geer, Michael W T Tanck, Diana van Stijn-Bringas, Dimitriades, Cathelijn E M Aarts, Sanne M Dietz, Robin van Bruggen, Nina A Schweintzger, Werner Zenz, Marieke Emonts, Dace Zavadska, Marko Pokorn, Effua Usuf, Henriette A Moll, Luregn J Schlapbach, Enitan D Carrol, Stephane Paulus, Maria Tsolia, Colin Fink, Shunmay Yeung, Chisato Shimizu, Adriana Tremoulet, Rachel Galassini, Victoria J Wright, Federico Martinón-Torres, Jethro Herberg, Jane Burns, Michael Levin, Taco W Kuijpers, EUCLIDS Consortium, PERFORM Consortium and UK Kawasaki Disease Genetics Study Network
Doi:
Factor de impacto:
Doi:
SINGLE-DOSE NIRSEVIMAB FOR PREVENTION OF RSV IN PRETERM INFANTS
M. Pamela Griffin, Yuan Yuan, Therese Takas, Joseph B. Domachowske, Shabir A. Madhi, Paolo Manzoni, Eric A.F. Simões, Mark T. Esser, Anis A. Khan, Filip Dubovsky, Tonya Villafana and John P. DeVincenzo for the Nirsevimab Study Group*(Federico Martinón Torres)
Doi:
Factor de impacto:
Doi:
RESPIRATORY SYNCYTIAL VIRUS VACCINATION DURING PREGNANCY AND EFFECTS IN INFANTS
S.A. Madhi, F.P. Polack, P.A. Piedra, F.M. Munoz, A.A. Trenholme, E.A.F. Simões, G.K. Swamy, S. Agrawal, K. Ahmed, A. August, A.H. Baqui, A. Calvert, J. Chen, I. Cho, M.F. Cotton, C.L. Cutland, J.A. Englund, A. Fix, B. Gonik, L. Hammitt, P.T. Heath, J.N. de Jesus, C.E. Jones, A. Khalil, D.W. Kimberlin, R. Libster, C.J. Llapur, M. Lucero, G. Pérez Marc, H.S. Marshall, M.S. Masenya,F. Martinón‐Torres, J.K. Meece, T.M. Nolan, A. Osman, K.P. Perrett, J.S. Plested, P.C. Richmond, M.D. Snape, J.H. Shakib, V. Shinde, T. Stoney, D.N. Thomas, A.T. Tita, M.W. Varner, M. Vatish, K. Vrbicky, J. Wen, K. Zaman, H.J. Zar, G.M. Glenn, and L.F. Fries, for the Prepare Study Group*
Doi:
Factor de impacto:
Doi:
MAPPING GENOME VARIATION OF SARS-COV-2 WORLDWIDE HIGHLIGHTS THE IMPACT OF COVID-19 SUPER-SPREADERS
Alberto Gómez-Carballa, Xabier Bello, Jacobo Pardo-Seco, Federico Martinón-Torres, Antonio Salas
Doi:
bioRxiv
Factor de impacto:
Q1
Doi:
CLINICAL CHARACTERISTICS OF 58 CHILDREN WITH A PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY ASSOCIATED WITH SARS-COV-2
Elizabeth Whittaker; Alasdair Bamford; Julia Kenny; Myrsini Kaforou; Christine E. Jones; Priyen Shah; Padmanabhan Ramnarayan; Alain Fraisse; Owen Miller; Patrick Davies; Filip Kucera; Joe Brierley; Marilyn McDougall; Michael Carter; Adriana Tremoulet; Chisato Shimizu Jethro Herberg; Jane C. Burns; Hermione Lyall; Michael Levin; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia (Federico Martinón-Torres)
Doi:
JAMA
Factor de impacto:
Q1
Doi:
RNA-SEQ DATA-MINING ALLOWS THE DISCOVERY OF TWO LONG NON-CODING RNA BIOMARKERS OF VIRAL INFECTION IN HUMANS
Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, María José Currás-Tuala, Sara Pischedda, Sandra Viz-Lasheras, Xabier Bello, Federico Martinón-Torres and Antonio Salas
Doi:
International J Molecular Sciences
Factor de impacto:
Q1
Doi:
COST OF RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTION MANAGEMENT IN YOUNG CHILDREN AT THE REGIONAL AND GLOBAL LEVEL: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, Lucero MG, Nillos LT, Kyaw MH, Kieffer A, Tong S, Campbell H, Beutels P, Nair H; RESCEU Investigators
Doi:
J Infect Dis.
Factor de impacto:
Q1
Doi:
IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS OF SUSCEPTIBILITY AND SEVERITY IN ADULT RESPIRATORY SYNCYTIAL VIRUS INFECTIONS.
Wiseman DJ, Thwaites RS, Drysdale SB, Janet S, Donaldson GC, Wedzicha JA, Openshaw PJ; RESCEU Investigators
Doi:
J Infect Dis.
Factor de impacto:
Q1
Doi:
LOW SENSITIVITY OF BINAXNOW RSV IN INFANTS.
Zuurbier RP, Bont LJ, Langedijk AC, Hamer M, Korsten K, Drysdale SB, Snape MD, Robinson H, Pollard AJ, Martinón-Torres F, Rodríguez-Tenreiro Sánchez C, Gómez-Carballa A, Dacosta-Urbieta AI, Heikkinen T, Cunningham S, van Houten MA, Wildenbeest JG; RESCEU Investigators .
Doi:
J Infect Dis.
Factor de impacto:
Q1
Doi:
A META-ANALYSIS OF MULTIPLE WHOLE BLOOD GENE EXPRESSION DATA UNVEILS A DIAGNOSTIC HOST-RESPONSE TRANSCRIPT SIGNATURE FOR RESPIRATORY SYNCYTIAL VIRUS
Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, Xabier Bello, Federico Martinón-Torres, and Antonio Salas
Int. J. Mol. Sci.
Factor de impacto:
Q1
Doi:
RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTIONS IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: SYSTEMATIC REVIEW AND META-ANALYSIS.
Chaw PS, Hua L, Cunningham S, Campbell H, Mikolajczyk R, Nair H; RESCEU Investigators (Nair H, Campbell H, Shi T, Zhang S, Li Y, Hua L, Openshaw P, Wedzicha J, Falsey A, Miller M, Bont L, Pollard A, Molero E, Martinon-Torres F, Heikkinen T, Meijer A, Fischer TK, van den Berge M, Giaquinto C, Mikolajczyk R, Chaw PS, Gallichan S, Kieffer A, Demont C, Hackett J, Cai B, Knirsch C, Leach A, Stoszek S, Cheret A, Gavart S, Aerssens J, Fuentes R, Rosen B)
J Infect Dis.
Factor de impacto:
Q1
Doi:
PHARMACOKINETICS, SAFETY AND ANTIVIRAL EFFECTS OF MULTIPLE DOSES OF THE RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN INHIBITOR, JNJ-53718678, IN INFANTS HOSPITALIZED WITH RSV INFECTION: A RANDOMIZED PHASE 1B STUDY
Federico Martinón-Torres, Sarah Rusch, Dymphy Huntjens, Bart Remmerie, Johan Vingerhoets, Katie McFadyen, Fernando Ferrero, Eugenio Baraldi, Pablo Rojo, Cristina Epalza, Marita Stevens
Clin Infect Dis
Factor de impacto:
Q1
Doi:
DIAGNOSTIC CRITERIA FOR ACUTE FPIES: WHAT ARE WE MISSING?
Marta Vazquez-Ortiz, Laura Argiz, Adrianna Machinena, Luis Echeverria, Cristina Blasco, Ana Prieto, Sonsoles Infante, Leticia Vila, Emilio Garcia, Purificación Gonzalez-Delgado, SoniaVazquez-Cortes, Simona Barni, Frederico Martinon-Torres, BIO-FPIES study network
J Allergy Clin Immunol Pract
Factor de impacto:
Q1
Doi:
EVALUATION OF THE IMPACT OF THE SPANISH CONSENSUS DOCUMENT ON THE APPROACH TO OSTEOARTICULAR INFECTIONS IN SPAIN THROUGH THE PAEDIATRICS OSTEOARTICULAR INFECTIONS NETWORK (RIOPED).
Nunez Cuadros, Esmeralda; Calvo Rey, Cristina; Saavedra-Lozano, Jesus and Red RIOPED (Federico Martinón and Irene Rivero)
An Ped
Factor de impacto:
Q4
Doi:
IMMUNOGENICITY, TRANSPLACENTAL TRANSFER OF PERTUSSIS ANTIBODIES AND SAFETY FOLLOWING PERTUSSIS IMMUNIZATION DURING PREGNANCY:EVIDENCE FROM A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Kirsten P. Perrett, Scott A. Halperin, Terry Nolan, Cristina Martínez Pancorbo, Bruce Tapiero, Federico Martinón-Torres, Zbynek Stranak, Miia Virta, Otto G. Vanderkooi, Pavel Kosina, Maria Begoña Encinas Pardilla, Ignacio Cristobal García, Gian Vincenzo Zuccotti, Lusine Kostanyanm, Nadia Meyer, Maria Angeles Ceregido, Brigitte Cheuvart, Sherine O. Kuriyakose, Manuel Marcos Fernández, Miguel Ángel Rodríguez Zambrano, Adrián Martín García, Juan Eloy Asenjo de la Fuente, Maria Dolores Camacho Marín, María de la Calle Fernández-Miranda, Yolanda Romero Espinar, Paola Giovanna Marchisio, Paolo Manzoni, Narcisa Mesaros
Vaccine
Factor de impacto:
Q3
Doi:
IMPACT OF TETANUS-DIPHTHERIA-ACELLULAR PERTUSSIS IMMUNIZATION DURING PREGNANCY ON SUBSEQUENT INFANT IMMUNIZATION SERORESPONSES: FOLLOW-UP FROM A LARGE RANDOMIZED PLACEBO-CONTROLLED TRIAL
1Kirsten P. Perrett, Scott A. Halperin, Terry Nolan, Alfonso Carmona Martínez, Federico Martinón-Torres, Jose García-Sicilia, Miia Virta , Otto G. Vanderkooi, Gian Vincenzo Zuccotti, Paolo Manzoni, Lusine Kostanyan, Nadia Meyer, Maria Angeles Ceregido, Brigitte Cheuvart , Sherine O. Kuriyakose l, Zbynek Stranak, Jose M. Merino Arribas, María José Cilleruelo Ortega, Mariano Miranda-Valdivieso, Begoña Arias Novas, Jose Tomas Ramos Amador, Felix Omeñaca, Manuel Baca, Paola Giovanna Marchisio, Narcisa Mesaros
Vaccine
Factor de impacto:
Q3
Doi:
SURVEY BY TEDDY EUROPEAN NETWORK OF EXCELLENCE FOR PAEDIATRIC CLINICAL RESEARCH DEMONSTRATES POTENTIAL FOR EUROPE-WIDE TRIALS
Ruggieri L, Bonifazi D, Landi A, Bonifazi F, Bartoloni F, Costello M, Felisi MG, Gasthuys E, Godo A, Martinon Torres F, Nadal D, Nuytinck L, Rocchi F, Turner M, Ceci A
Acta paed
Factor de impacto:
Q2
Doi:
REACTIONS ON RE-EXPOSURE FOLLOWING NEGATIVE AND INCONCLUSIVE FOLLOW-UP FOOD CHALLENGES IN CHILDREN WITH ACUTE FPIES
Laura Argiz, Sonsoles Infante, Adrianna Machinena, Mariona Pascal, Luis Echeverria, Simona Barni, Teresa Garriga-Baraut, Stefania Arasi, Jose Domingo Moure, Alberto Gomez-Carballa, Federico Martinon-Torres, Robert J Boyle, Marta Vazquez-Ortiz, BIO-FPIES study network
J Allergy Clin Immunol Pract
Factor de impacto:
Q1
Doi:
ENFERMEDAD MENINGOCÓCICA: ¿PODEMOS PREDECIR LO IMPREDECIBLE?
Federico Martinón-Torresy Antoni Trillac
Med Clin
Factor de impacto:
Q3
Doi: